Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors.

Azimi A, Caramuta S, Seashore-Ludlow B, Boström J, Robinson JL, Edfors F, Tuominen R, Kemper K, Krijgsman O, Peeper DS, Nielsen J, Hansson J, Egyhazi Brage S, Altun M, Uhlen M, Maddalo G.

Mol Syst Biol. 2018 Mar 5;14(3):e7858. doi: 10.15252/msb.20177858.

2.

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.

Azimi A, Tuominen R, Costa Svedman F, Caramuta S, Pernemalm M, Frostvik Stolt M, Kanter L, Kharaziha P, Lehtiö J, Hertzman Johansson C, Höiom V, Hansson J, Egyhazi Brage S.

Cell Death Dis. 2017 Aug 31;8(8):e3029. doi: 10.1038/cddis.2017.406.

3.

Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.

Al-Khanbashi M, Caramuta S, Alajmi AM, Al-Haddabi I, Al-Riyami M, Lui WO, Al-Moundhri MS.

PLoS One. 2016 Apr 11;11(4):e0152032. doi: 10.1371/journal.pone.0152032. eCollection 2016.

4.

Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.

Juhlin CC, Stenman A, Haglund F, Clark VE, Brown TC, Baranoski J, Bilguvar K, Goh G, Welander J, Svahn F, Rubinstein JC, Caramuta S, Yasuno K, Günel M, Bäckdahl M, Gimm O, Söderkvist P, Prasad ML, Korah R, Lifton RP, Carling T.

Genes Chromosomes Cancer. 2015 Sep;54(9):542-54. doi: 10.1002/gcc.22267. Epub 2015 May 29.

5.

Extravirgin olive oil up-regulates CB₁ tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms.

Di Francesco A, Falconi A, Di Germanio C, Micioni Di Bonaventura MV, Costa A, Caramuta S, Del Carlo M, Compagnone D, Dainese E, Cifani C, Maccarrone M, D'Addario C.

J Nutr Biochem. 2015 Mar;26(3):250-8. doi: 10.1016/j.jnutbio.2014.10.013. Epub 2014 Dec 3.

PMID:
25533906
6.

microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome.

Akçakaya P, Caramuta S, Åhlen J, Ghaderi M, Berglund E, Östman A, Bränström R, Larsson C, Lui WO.

Br J Cancer. 2014 Nov 25;111(11):2091-102. doi: 10.1038/bjc.2014.548. Epub 2014 Oct 30.

7.

MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.

Velázquez-Fernández D, Caramuta S, Özata DM, Lu M, Höög A, Bäckdahl M, Larsson C, Lui WO, Zedenius J.

Eur J Endocrinol. 2014 Mar 8;170(4):583-91. doi: 10.1530/EJE-13-0817. Print 2014 Apr.

8.

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.

Andreasson A, Kiss NB, Caramuta S, Sulaiman L, Svahn F, Bäckdahl M, Höög A, Juhlin CC, Larsson C.

Epigenetics. 2013 Dec;8(12):1347-54. doi: 10.4161/epi.26686. Epub 2013 Oct 22.

9.

Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma.

Caramuta S, Lee L, Ozata DM, Akçakaya P, Georgii-Hemming P, Xie H, Amini RM, Lawrie CH, Enblad G, Larsson C, Berglund M, Lui WO.

Blood Cancer J. 2013 Oct 11;3:e152. doi: 10.1038/bcj.2013.49.

10.

MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.

Xie H, Lee L, Caramuta S, Höög A, Browaldh N, Björnhagen V, Larsson C, Lui WO.

J Invest Dermatol. 2014 Feb;134(2):507-517. doi: 10.1038/jid.2013.355. Epub 2013 Aug 20.

11.

Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.

Caramuta S, Lee L, Ozata DM, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui WO.

Endocr Relat Cancer. 2013 Jul 4;20(4):551-64. doi: 10.1530/ERC-13-0098. Print 2013 Aug.

12.

miR-205 expression promotes cell proliferation and migration of human cervical cancer cells.

Xie H, Zhao Y, Caramuta S, Larsson C, Lui WO.

PLoS One. 2012;7(10):e46990. doi: 10.1371/journal.pone.0046990. Epub 2012 Oct 3.

13.

Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.

Åkerström T, Crona J, Delgado Verdugo A, Starker LF, Cupisti K, Willenberg HS, Knoefel WT, Saeger W, Feller A, Ip J, Soon P, Anlauf M, Alesina PF, Schmid KW, Decaussin M, Levillain P, Wängberg B, Peix JL, Robinson B, Zedenius J, Bäckdahl M, Caramuta S, Iwen KA, Botling J, Stålberg P, Kraimps JL, Dralle H, Hellman P, Sidhu S, Westin G, Lehnert H, Walz MK, Åkerström G, Carling T, Choi M, Lifton RP, Björklund P.

PLoS One. 2012;7(7):e41926. doi: 10.1371/journal.pone.0041926. Epub 2012 Jul 27.

14.

The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.

Özata DM, Caramuta S, Velázquez-Fernández D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui WO.

Endocr Relat Cancer. 2011 Oct 27;18(6):643-55. doi: 10.1530/ERC-11-0082. Print 2011 Oct.

15.

miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer.

Akçakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H, Lui WO.

Int J Oncol. 2011 Aug;39(2):311-8. doi: 10.3892/ijo.2011.1043. Epub 2011 May 13.

PMID:
21573504
16.

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.

Caramuta S, Egyházi S, Rodolfo M, Witten D, Hansson J, Larsson C, Lui WO.

J Invest Dermatol. 2010 Aug;130(8):2062-70. doi: 10.1038/jid.2010.63. Epub 2010 Apr 1.

17.

Multiplex protein assays based on real-time magnetic nanotag sensing.

Osterfeld SJ, Yu H, Gaster RS, Caramuta S, Xu L, Han SJ, Hall DA, Wilson RJ, Sun S, White RL, Davis RW, Pourmand N, Wang SX.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20637-40. doi: 10.1073/pnas.0810822105. Epub 2008 Dec 12.

18.

Suspension bead array branch migration displacement assay for rapid STR analysis.

Villablanca A, Karhanek M, Caramuta S, Yu H, Jejelowo O, Webb CD, Pourmand N.

Electrophoresis. 2008 Oct;29(19):4109-14. doi: 10.1002/elps.200700866.

PMID:
18958881
19.

Branch migration displacement assay with automated heuristic analysis for discrete DNA length measurement using DNA microarrays.

Pourmand N, Caramuta S, Villablanca A, Mori S, Karhanek M, Wang SX, Davis RW.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6146-51. Epub 2007 Mar 27.

20.

Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.

Perrone F, Suardi S, Pastore E, Casieri P, Orsenigo M, Caramuta S, Dagrada G, Losa M, Licitra L, Bossi P, Staurengo S, Oggionni M, Locati L, Cantu G, Squadrelli M, Carbone A, Pierotti MA, Pilotti S.

Clin Cancer Res. 2006 Nov 15;12(22):6643-51. Erratum in: Clin Cancer Res. 2007 Jul 15;13(14):4313.

21.

Phenotype-genotype correlation: challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.

Frattini M, Perrone F, Suardi S, Balestra D, Caramuta S, Colombo F, Licitra L, Cantù G, Pierotti MA, Pilotti S.

Head Neck. 2006 Oct;28(10):909-15.

PMID:
16906516
22.

Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPR.

Caramuta S, De Cecco L, Reid JF, Zannini L, Gariboldi M, Kjeldsen L, Pierotti MA, Delia D.

Int J Cancer. 2006 Oct 1;119(7):1599-606.

23.

9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.

Perrone F, Tamborini E, Dagrada GP, Colombo F, Bonadiman L, Albertini V, Lagonigro MS, Gabanti E, Caramuta S, Greco A, Torre GD, Gronchi A, Pierotti MA, Pilotti S.

Cancer. 2005 Jul 1;104(1):159-69.

24.

Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.

De Cecco L, Marchionni L, Gariboldi M, Reid JF, Lagonigro MS, Caramuta S, Ferrario C, Bussani E, Mezzanzanica D, Turatti F, Delia D, Daidone MG, Oggionni M, Bertuletti N, Ditto A, Raspagliesi F, Pilotti S, Pierotti MA, Canevari S, Schneider C.

Oncogene. 2004 Oct 21;23(49):8171-83.

PMID:
15377994

Supplemental Content

Loading ...
Support Center